As of 2026-03-25, the EV/EBITDA ratio of Inhibrx Inc (INBX) is -7.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INBX's latest enterprise value is 864.59 mil USD. INBX's TTM EBITDA according to its financial statements is -108.75 mil USD. Dividing these 2 quantities gives us the above INBX EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 14.8x | 14.0x |
| Forward P/E multiples | 15.4x - 20.2x | 18.0x |
| Fair Price | (93.73) - 2,501.12 | 1,060.03 |
| Upside | -248.5% - 3862.5% | 1579.4% |
| Date | EV/EBITDA |
| 2026-03-24 | -7.95 |
| 2026-03-23 | -8.15 |
| 2026-03-20 | -7.66 |
| 2026-03-19 | -8.18 |
| 2026-03-18 | -8.69 |
| 2026-03-17 | -8.83 |
| 2026-03-16 | -8.77 |
| 2026-03-13 | -8.70 |
| 2026-03-12 | -8.78 |
| 2026-03-11 | -9.34 |
| 2026-03-10 | -9.09 |
| 2026-03-09 | -9.12 |
| 2026-03-06 | -8.76 |
| 2026-03-05 | -8.96 |
| 2026-03-04 | -9.49 |
| 2026-03-03 | -9.45 |
| 2026-03-02 | -9.87 |
| 2026-02-27 | -9.42 |
| 2026-02-26 | -9.84 |
| 2026-02-25 | -10.24 |
| 2026-02-24 | -10.14 |
| 2026-02-23 | -9.75 |
| 2026-02-20 | -10.03 |
| 2026-02-19 | -10.35 |
| 2026-02-18 | -10.42 |
| 2026-02-17 | -10.04 |
| 2026-02-13 | -9.65 |
| 2026-02-12 | -10.49 |
| 2026-02-11 | -10.47 |
| 2026-02-10 | -10.65 |
| 2026-02-09 | -11.07 |
| 2026-02-06 | -10.73 |
| 2026-02-05 | -10.41 |
| 2026-02-04 | -10.55 |
| 2026-02-03 | -10.89 |
| 2026-02-02 | -10.51 |
| 2026-01-30 | -9.71 |
| 2026-01-29 | -9.21 |
| 2026-01-28 | -9.40 |
| 2026-01-27 | -9.34 |
| 2026-01-26 | -9.14 |
| 2026-01-23 | -9.49 |
| 2026-01-22 | -10.14 |
| 2026-01-21 | -9.55 |
| 2026-01-20 | -9.26 |
| 2026-01-16 | -9.17 |
| 2026-01-15 | -9.11 |
| 2026-01-14 | -9.66 |
| 2026-01-13 | -9.31 |
| 2026-01-12 | -9.66 |